Innate and Adaptive Immune Markers in Farming Lifestyle and Early Atopic Diseases
农业生活方式和早期特应性疾病中的先天性和适应性免疫标志物
基本信息
- 批准号:10633369
- 负责人:
- 金额:$ 43.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-07 至 2028-03-31
- 项目状态:未结题
- 来源:
- 关键词:ATAC-seqAllergensAllergicAllergic DiseaseAnti-Allergic AgentsAsthmaAtopic DermatitisBifidobacteriumBiological MarkersBirthBloodCellsClinical DataCommunitiesConstitutionConstitutionalDevelopmentDiseaseDisease OutcomeEnrollmentEpigenetic ProcessEpithelial CellsEpitheliumExtrinsic asthmaFamilyFarmFecesFlow CytometryFoodFood HypersensitivityFrequenciesGene ExpressionGenerationsGenetic TranscriptionGoalsHomingIgEImmuneImmunityImmunologic MarkersImmunophenotypingIn VitroIndividualInfantInflammatoryInterventionIntestinal permeabilityKLRB1 geneLife StyleLipopolysaccharidesMaintenanceMeasuresMediatingMemoryMennoniteModificationMyeloid CellsOutcomePathogenicityPermeabilityPhenotypePopulationPrevention strategyProliferatingRegulatory T-LymphocyteReproducibilityRiskRoleSamplingSchool-Age PopulationSignal TransductionSiteSkinSterilityStimulusT cell differentiationT-LymphocyteTLR4 geneTestingTrainingUmbilical Cord BloodViralWaterWorkatopyclinical developmentcohortcytokineearly detection biomarkersepigenomeexperiencefood antigenfunctional outcomesgastrointestinalgastrointestinal epitheliumgut microbiomehigh riskin vivoinfancyinfant gut microbiomeintestinal barrierintestinal epitheliummicrobialmonocytenovelreceptorresponsesingle-cell RNA sequencingtranscriptome
项目摘要
Atopic constitution starts shortly after birth with atopic dermatitis (AD) and sensitization to foods, which is an
important marker for the potential development of clinical food allergy (FA). A farming lifestyle has been
reproducibly associated with a reduced risk of asthma and atopic disease at school-age. Sustained microbial
exposure experienced when living on farms is proposed to confer protection through priming of innate immune
populations/receptors, whereas increased monocyte activation and hyper-responsive cytokine response to
lipopolysaccharide (LPS) stimulation was associated with increased risk of allergic asthma. Epigenetic
modifications in myeloid cells can lead to a change in functional potential to a second stimulus, either an
enhanced or suppressed response. This long-lived modification in immune potential, a concept known as trained
immunity, can lead to an array of functional outcomes, similar to the T cell differentiation outcomes that they
influence. Farmlife protection is also proposed to be mediated through expansion of regulatory T (Treg) cells.
Through epigenetic mechanisms or direct interaction with immune cells, microbial metabolites promote
generation of Tregs. This can reinforce tolerance through maintenance of epithelial barrier integrity, which is
known to be compromised in skin in AD, facilitating epicutaneous allergen sensitization and in gastrointestinal
sites in FA. Despite several large birth cohorts, the early mechanisms and biomarkers of AD and FA are poorly
characterized, although the emerging strategies for prevention call for a need to identify those at risk.
Our preliminary studies in the “Zooming in to Old Order Mennonites” (ZOOM)1 birth cohort identified novel
memory effector Th2 subpopulations in infancy as a marker of development of allergic sensitization in infants
born to Rochester urban families (ROC). In comparison, our studies found a higher frequency of gut-homing
(β7+) Tregs and Tregs that express TIGIT, an inhibitory co-stimulatory molecule, in infants from Old Order
Mennonites (OOM), a traditional agrarian community protected against atopic diseases. In addition, ROC infants
demonstrated a hyper-inflammatory monocyte response in cord blood. Utilizing samples and clinical data
collected under the already enrolled ZOOM1 cohort (n=160) and to be enrolled expansion cohort ZOOM 2
(n=120), we will be testing our central hypothesis that infants who will develop atopic diseases generate Th2-
skewed T cell populations in early infancy, whereas the protected infants develop gut-homing suppressive Tregs,
and monocytes hyporesponsive to LPS and viral targets. We have three specific aims: Aim 1 will assess
infant adaptive and innate immune markers in farming and urban lifestyles associated with protection
and atopic disease outcomes. Aim 2 will evaluate the role of T and innate cell transcriptome and
epigenome on atopic disease outcomes. Aim 3 will measure the association between gut barrier
function, farming lifestyle, and atopic diseases. Upon completion of this work, we expect to identify
mechanisms and biomarkers associated with anti-allergic immunity.
特应特应性皮炎(AD)出生后不久开始,并且对食物的敏感性
临床食品过敏(FA)潜在发展的重要标志。农业生活方式已经
可重复与学龄时哮喘和特应性疾病的风险降低有关。持续微生物
建议生活在农场时经历的暴露是通过启动先天免疫来提供保护的
种群/受体,而单核细胞激活增加和对细胞因子对
脂多糖(LPS)模拟与过敏性哮喘的风险增加有关。表观遗传学
在
增强或抑制的响应。这种长期的免疫潜力修改,一个被称为训练的概念
免疫力,可以导致一系列功能结果,类似于它们的T细胞分化结果
影响。还建议通过扩展调节t(Treg)细胞来介导农业生物保护。
通过表观遗传机制或与免疫细胞直接相互作用,微生物代谢物促进
产生Tregs。这可以通过维持上皮屏障完整性来增强耐受性,即
已知在AD中受到皮肤的损害,支持表皮过敏原感应和胃肠道
FA的网站。尽管有几个大的出生队列,但AD和FA的早期机制和生物标志物还是很差的
表征,尽管预防的新兴策略要求确定有风险的人。
我们在“缩放到旧顺序的门诺派”(Zoom)1生日队列中的初步研究确定了小说
记忆效应子Th2在婴儿期的亚群,作为婴儿过敏性感觉发展的标志
罗切斯特城市家庭(ROC)出生。相比之下,我们的研究发现肠道的频率更高
(β7+)表达tigit的treg和tregs,一种抑制性共刺激分子,来自旧顺序的婴儿
Mennonites(OOM),一个传统的农业社区,免受特应疾病的保护。另外,ROC婴儿
在脐带血中证明了过度炎症的单核细胞反应。利用样品和临床数据
在已经注册的Zoom1队列(n = 160)下收集,并招募扩展队列Zoom 2
(n = 120),我们将测试我们的中心假设,即会产生特应性疾病的婴儿会产生Th2-
偏斜的T细胞群体在婴儿早期期,而受保护的婴儿会出现肠道抑制性的Treg,
和单核细胞对LP和病毒靶标的反应。我们有三个具体的目标:AIM 1将评估
婴儿适应性和先天免疫标记在农业和城市生活方式中与保护相关
和特应性疾病的结果。 AIM 2将评估T和先天细胞转录组的作用以及
特应性疾病结局的表观基因组。 AIM 3将衡量肠道障碍之间的关联
功能,农业生活方式和特应性疾病。完成这项工作后,我们希望确定
与抗过敏性免疫相关的机制和生物标志物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kirsi Jarvinen-Seppo其他文献
Kirsi Jarvinen-Seppo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kirsi Jarvinen-Seppo', 18)}}的其他基金
Expecting Mothers' Study of Consumption or Avoidance of Peanut and Egg (ESCAPE)
准妈妈食用或避免花生和鸡蛋的研究(ESCAPE)
- 批准号:
10733927 - 财政年份:2023
- 资助金额:
$ 43.89万 - 项目类别:
Biomarkers of Atopy Beginning Early (BABE)
特应性早期开始的生物标志物 (BABE)
- 批准号:
10633364 - 财政年份:2023
- 资助金额:
$ 43.89万 - 项目类别:
Role of B. infantis in Development of Atopic Diseases
婴儿双歧杆菌在特应性疾病发展中的作用
- 批准号:
10286718 - 财政年份:2021
- 资助金额:
$ 43.89万 - 项目类别:
Role of B. infantis in Development of Atopic Diseases
婴儿双歧杆菌在特应性疾病发展中的作用
- 批准号:
10432099 - 财政年份:2021
- 资助金额:
$ 43.89万 - 项目类别:
Development of Mucosal and Systemic Immunity and Risk of Food Allergy
粘膜和系统免疫的发展以及食物过敏的风险
- 批准号:
10158965 - 财政年份:2020
- 资助金额:
$ 43.89万 - 项目类别:
Impact of Breast Milk on Infant Gut Microbiome
母乳对婴儿肠道微生物群的影响
- 批准号:
9756486 - 财政年份:2018
- 资助金额:
$ 43.89万 - 项目类别:
Development of Mucosal and Systemic Immunity and Risk of Food Allergy
粘膜和系统免疫的发展以及食物过敏的风险
- 批准号:
10265645 - 财政年份:2017
- 资助金额:
$ 43.89万 - 项目类别:
Impact of Maternal Diet and Supplements on Breast Milk Composition
母亲饮食和补充剂对母乳成分的影响
- 批准号:
9912500 - 财政年份:2017
- 资助金额:
$ 43.89万 - 项目类别:
Development of Mucosal and Systemic Immunity and Risk of Food Allergy
粘膜和系统免疫的发展以及食物过敏的风险
- 批准号:
9895622 - 财政年份:2017
- 资助金额:
$ 43.89万 - 项目类别:
相似国自然基金
花生主要过敏原 Ara h 3 致敏的结构生物学基础
- 批准号:32372441
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
鱼类过敏原小清蛋白广谱性模拟抗原的精准构筑及构效关系研究
- 批准号:32372439
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
过敏原特异性Th2记忆前体细胞鉴定及其形成机制研究
- 批准号:82371740
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
白色念珠菌过敏原通过CGRP-IL-21-PIEZO1轴促进T细胞-小胶质细胞-神经元通讯介导瘙痒
- 批准号:82371797
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
过敏原RNA疫苗促进过敏性鼻炎中嗜酸性粒细胞分泌保护素D1诱导Treg产生机制
- 批准号:82371122
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Control of ST2+ Treg Development in Allergic Disease by Bcl6 and Sex Hormone Receptors
Bcl6 和性激素受体控制过敏性疾病中 ST2 Treg 的发育
- 批准号:
10633229 - 财政年份:2022
- 资助金额:
$ 43.89万 - 项目类别:
Role of a Novel Interferon Responsive T Cell Subset in Allergy and Asthma
新型干扰素反应性 T 细胞亚群在过敏和哮喘中的作用
- 批准号:
10708060 - 财政年份:2022
- 资助金额:
$ 43.89万 - 项目类别:
Control of ST2+ Treg Development in Allergic Disease by Bcl6 and Sex Hormone Receptors
Bcl6 和性激素受体控制过敏性疾病中 ST2 Treg 的发育
- 批准号:
10535286 - 财政年份:2022
- 资助金额:
$ 43.89万 - 项目类别:
Role of a Novel Interferon Responsive T Cell Subset in Allergy and Asthma
新型干扰素反应性 T 细胞亚群在过敏和哮喘中的作用
- 批准号:
10588108 - 财政年份:2022
- 资助金额:
$ 43.89万 - 项目类别: